triple negative breast cancer tnbc cell line bt549 (ATCC)
Structured Review
Triple Negative Breast Cancer Tnbc Cell Line Bt549, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 3004 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/triple+negative+breast+cancer+cells+lines+bt549/BT-549/10__1091_slash_mbc__e25___07___0340-244-2-14
Average 99 stars, based on 3004 article reviews
Images
Related Articles
other:Article Title: ATR pathway inhibition is synthetically lethal in cancer cells with ERCC1 deficiency Article Snippet: Triple negative breast cancer cells lines BT549 and HCC1806 and non-small cell lung cancer cells lines A549 and H157 were obtained from Article Title: ATR Pathway Inhibition Is Synthetically Lethal in Cancer Cells with ERCC1 Deficiency Article Snippet: Triple-negative breast cancer cells lines BT549 and HCC1806 and non–small cell lung cancer cells lines A549 and H157 were obtained from Article Title: ATR pathway inhibition is synthetically lethal in cancer cells with ERCC1 deficiency Article Snippet: U2OS and 293T cells were obtained from the |
